The ins and outs of anthrax toxin
S Friebe, FG Van der Goot, J Bürgi - Toxins, 2016 - mdpi.com
Anthrax is a severe, although rather rare, infectious disease that is caused by the Gram-
positive, spore-forming bacterium Bacillus anthracis. The infectious form is the spore and the …
positive, spore-forming bacterium Bacillus anthracis. The infectious form is the spore and the …
Engineering proteins for cell entry
X Feng, R Chang, H Zhu, Y Yang, Y Ji… - Molecular …, 2023 - ACS Publications
Proteins are essential for life, as they participate in all vital processes in the body. In the past
decade, delivery of active proteins to specific cells and organs has attracted increasing …
decade, delivery of active proteins to specific cells and organs has attracted increasing …
Nanomedicine directs neuronal differentiation of neural stem cells via silencing long noncoding RNA for stroke therapy
B Lin, L Lu, Y Wang, Q Zhang, Z Wang, G Cheng… - Nano Letters, 2021 - ACS Publications
Transplantation of neural stem cells (NSCs) is a promising treatment paradigm to replace
lost neurons and reconstruct the damaged neural circuit after ischemic stroke. However …
lost neurons and reconstruct the damaged neural circuit after ischemic stroke. However …
Anthrax toxins regulate pain signaling and can deliver molecular cargoes into ANTXR2+ DRG sensory neurons
Bacterial products can act on neurons to alter signaling and function. In the present study,
we found that dorsal root ganglion (DRG) sensory neurons are enriched for ANTXR2, the …
we found that dorsal root ganglion (DRG) sensory neurons are enriched for ANTXR2, the …
Delivery of non-native cargo into mammalian cells using anthrax lethal toxin
AE Rabideau, BL Pentelute - ACS chemical biology, 2016 - ACS Publications
The intracellular delivery of peptide and protein therapeutics is a major challenge due to the
plasma membrane, which acts as a barrier between the extracellular environment and the …
plasma membrane, which acts as a barrier between the extracellular environment and the …
Targeted intracellular delivery of Cas13 and Cas9 nucleases using bacterial toxin-based platforms
Targeted delivery of therapeutic proteins toward specific cells and across cell membranes
remains major challenges. Here, we develop protein-based delivery systems utilizing …
remains major challenges. Here, we develop protein-based delivery systems utilizing …
The LOXL1 antisense RNA 1 (LOXL1-AS1)/microRNA-423-5p (miR-423-5p)/ectodermal-neural cortex 1 (ENC1) axis promotes cervical cancer through the mitogen …
P Zhang, F Zhao, K Jia, X Liu - Bioengineered, 2022 - Taylor & Francis
As the fourth commonest malignancy among females worldwide, cervical cancer (CC) poses
a huge challenge to human health. The pivotal regulatory roles of lncRNAs in cancers have …
a huge challenge to human health. The pivotal regulatory roles of lncRNAs in cancers have …
Targeting non-coding RNA for glioblastoma therapy: the challenge of overcomes the blood-brain barrier
RK Sharma, C Calderon… - Frontiers in Medical …, 2021 - frontiersin.org
Glioblastoma (GBM) is the most malignant form of all primary brain tumors, and it is
responsible for around 200,000 deaths each year worldwide. The standard therapy for GBM …
responsible for around 200,000 deaths each year worldwide. The standard therapy for GBM …
Repurposing bacterial toxins for intracellular delivery of therapeutic proteins
GL Beilhartz, SN Sugiman-Marangos… - Biochemical …, 2017 - Elsevier
Despite enormous efforts, achieving efficacious levels of proteins inside mammalian cells
remains one of the greatest challenges in biologics-based drug discovery and development …
remains one of the greatest challenges in biologics-based drug discovery and development …